Elderly survivors with homozygous sickle cell disease.

Elderly survivors with homozygous sickle cell disease.

Detalles Bibliográficos
Main Authors:	Serjeant, G, Higgs, D, Hambleton, I
Formato:	Journal article
Idioma:	English
Publicado:	2007

Títulos similares

Are there clinical phenotypes of homozygous sickle cell disease?
por: Alexander, N, et al.
Publicado: (2004)

The changing face of homozygous sickle cell disease: 102 patients over 60 years.
por: Serjeant, G, et al.
Publicado: (2009)

The haematology of homozygous sickle cell disease after the age of 40 years
por: Morris, J, et al.
Publicado: (1991)

Sickle Cell-Hemoglobin D Iran: A Benign Sickle Cell Syndrome
por: Serjeant, B, et al.
Publicado: (1982)

The red cell distribution width in sickle cell disease--is it of clinical value?
por: Thame, M, et al.
Publicado: (1991)

Pulse oximetry in a cohort study of sickle cell disease
por: Homi, J, et al.
Publicado: (1997)

Phenotype/genotype relationships in sickle cell disease: a pilot twin study.
por: Weatherall, M, et al.
Publicado: (2005)

Malaria as a cause of morbidity and mortality in children with homozygous sickle cell disease on the coast of Kenya
por: Komba, A, et al.
Publicado: (2009)

Blood mononuclear cells and platelets have abnormal fatty acid composition in homozygous sickle cell disease
por: Okpala, Iheanyi, et al.
Publicado: (2004)

The interaction of alpha thalassaemia and sickle cell-beta zero thalassaemia.
por: Vyas, P, et al.
Publicado: (1988)

Genetic complexity in sickle cell disease.
por: Higgs, D, et al.
Publicado: (2008)

Clinical and biochemical effects of omega-3 fatty acid supplementation on patients with homozygous sickle cell disease
por: Daak, Ahmed A.
Publicado: (2011)

Medicine. Sickle cell disease at 100 years.
por: Orkin, S, et al.
Publicado: (2010)

Coagulation profile of Sudanese children with homozygous sickle cell disease and the effect of treatment with omega-3 fatty acid on the coagulation parameters
por: Awoda, Shiek, et al.
Publicado: (2017)

Sickle-cell disease.
por: Rees, D, et al.
Publicado: (2010)

Alpha-thalassaemia in Nigeria: Its interaction with sickle-cell disease
por: Falusi, A, et al.
Publicado: (2009)

Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease
por: Estcourt, L, et al.
Publicado: (2019)

Clinical and laboratory features of homozygous sickle cell patients in Tanzania; Malaria, infections and cerebral blood flow velocity.
por: Makani, J, et al.
Publicado: (2005)

Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease (Review)
por: Estcourt, L, et al.
Publicado: (2016)

Sickle cell disease: the price of cure
por: Roberts, I, et al.
Publicado: (2016)

UGT1A1 variation and gallstone formation in sickle cell disease.
por: Haverfield, E, et al.
Publicado: (2005)

Management of sickle cell disease in the community.
por: Brousse, V, et al.
Publicado: (2014)

Interventions for chronic kidney disease in people with sickle cell disease.
por: Roy, NB, et al.
Publicado: (2023)

Transcranial doppler in sickle cell disease in Africa
por: Ajala-Agbo, T, et al.
Publicado: (2007)

End Organ Affection in Sickle Cell Disease
por: Bathla, Tanvi, et al.
Publicado: (2024)

Preoperative blood transfusions for sickle cell disease
por: Estcourt, L, et al.
Publicado: (2016)

THE ASSESSMENT OF CEREBROVASCULAR-DISEASE IN CHILDREN WITH SICKLE-CELL DISEASE (SCD)
por: Hewes, D, et al.
Publicado: (1993)

Omega 3 (n-3) fatty acids down-regulate nuclear factor-kappa B (NF-kB) genen and blood cell adhesion molecule expression in patients with homozygous sickle cell disease
por: Daak, Ahmed A., et al.
Publicado: (2015)

Interventions for chronic kidney disease in people with sickle cell disease
por: Roy, N, et al.
Publicado: (2017)

Sickle cell disease in Africa: burden and research priorities.
por: Makani, J, et al.
Publicado: (2007)

Gene therapy in treating sickle cell anemia disease
por: Dol Ramli, Nur Amira, et al.
Publicado: (2022)

Gene therapy in treating sickle cell anemia disease
por: Dol Ramli, Nur Amira, et al.
Publicado: (2022)

Stroke in sickle cell disease in Africa: case report.
por: Makani, J
Publicado: (2004)

Gene therapy in a patient with sickle cell disease
por: Badat, M, et al.
Publicado: (2017)

Sickle cell disease: new opportunities and challenges in Africa.
por: Makani, J, et al.
Publicado: (2013)

A biophysical marker of severity in sickle cell disease
por: Mahadevan, L., et al.
Publicado: (2014)

[Sickle-cell disease: geographical distribution and population estimates].
por: Piel, F
Publicado: (2013)

Interventions for chronic kidney disease in people with sickle cell disease (Protocol)
por: Roy, N, et al.
Publicado: (2016)

Sickle cell retinopathy and hemoglobinopathies
por: Lutty, G, et al.
Publicado: (2007)

Cellular biophysical markers of hydroxyurea treatment in sickle cell disease
por: Du, E., et al.
Publicado: (2018)